ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Friendly User's Guide for the Timing of Nutritional Supplements

The Health Benefits of Manuka Honey

Increase Your Magnesium Intake

Vitamin D supplementation could ease IBS symptoms

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Mediterranean diet associated with lower risk of aggressive prostate cancer

 
Print Page
Email Article

Pediatric Chronic Pain: Prevalence, economic impact, and its relevance to the current opioid epidemic

  [ 2 votes ]   [ Discuss This Article ]
By PAINS Project • www.ProHealth.com • September 29, 2017


Pediatric Chronic Pain: Prevalence, economic impact, and its relevance to the current opioid epidemic
Reprinted with the permission of the PAINS Project
 
As our country is faced with addressing a surge in opioid abuse and misuse, pediatric chronic pain is often absent from policy proposals and funding initiatives despite its prevalence, economic impact, and relevance to the current opioid epidemic.
 
It is estimated that approximately 5-38% of children and adolescents suffer from chronic pain and, from 1994 to 2007, pediatric opioid prescription rates doubled. Pediatric chronic pain is associated with a significant level of economic burden in this country. Recent studies estimate that the economic cost of pediatric chronic pain is 19.5 billion dollars annually and it accounts for 11.8 billion dollars in total incremental health care expenditures, which is more than expenditures associated with obesity ($0.73 billion) and asthma ($9.23 billion) combined.
 
Children with chronic pain will soon be adults with chronic pain. Poor pain management in childhood not only affects the quality of life of children and their families, but also puts children at risk for continued and heightened impairment as they move into adulthood. Unfortunately, up to 73% of children and adolescents with chronic pain will continue to have pain in adulthood and are likely to develop new pain conditions.
 
The aim of this brief is to bring pediatric pain to the forefront of the discussion of pain management in this country.
 
We are pleased to announce the release of Pediatric Chronic Pain: Prevalence, economic impact, and its relevance to the current opioid epidemic, which is the tenth in a series of briefs profiling policy and educational issues important to improving chronic pain. We wish to thank contributors: Sarah R. Martin, PhD and Lonnie K. Zeltzer, MD of the Pediatric Pain and Palliative Care Program, Division of Pediatric Hematology-Oncology, David Geffen School of Medicine at UCLA and editors: Richard Payne, MD, John B. Francis Chair, Center for Practical Bioethics, Bob Twillman, PhD, FAPM, Executive Director, Academy of Integrative Pain Management and James Cleary, MD, FAChPM, Associate Professor of Medicine University of Wisconsin and Director of the Pain and Policy Studies Group.
 
This policy and educational brief is a product of the Pain Action Alliance to Implement a National Strategy (PAINS) and the Center for Practical Bioethics.

The Pain Action Alliance to Implement a National Strategy (PAINS) is a consortium of leaders working in professional societies, patient advocacy organizations, policy groups, consumers, payers and the private sector working together toward a common vision and mission. For more information, visit PAINSProject.org.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor® FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium

Natural Remedies

Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map